El compuesto se distribuye en formato liofilizado para investigacin con verificacin analtica por HPLC y espectrometra de masas
GLP-1 receptor agonists are a class of medications primarily licensed for the treatment of type 2 diabetes mellitus and, in some formulations, for weight management in adults with obesity or overweight with weight-related comorbidities
available evidence is limited to a single Phase 2 trial, and access should only be sought through registered clinical trials
Advertisement From the results of the trials weve seen, the recommendation is to continue taking GLP-1s for as long as possible and to think of obesity as a chronic disease, explains Dr
People lost over 20% of their weight, and 1 in 3 lost more than 25%
GLP-1 in Clinical Practice In the medical field, GLP-1 receptor agonists are prescribed to individuals struggling with obesity or overweight conditions